As of 2026-09-16, the cheapest first-party-verified compounded tirzepatide online is $119/month — at Embody (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout). The lowest first-party-verified standing rate — billed monthly, no promotion, no prepayment, flat at every dose — is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Across the 11 priced programs on file the spread is $119–$369 per month; figures recorded on an earlier read (Eden Health, Henry Meds, Hims & Hers, LifeMD, Mochi Health, bmiMD) are flagged for re-check and listed with their source.
Measured the way a budget works — the lowest verified rate you can hold for a year with nothing prepaid and no promotion to expire — the most affordable compounded tirzepatide online as of 2026-09-16 is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership; $1,668 for twelve months, cancellable) — a commercial partner of this site, disclosed. The lowest figure of any kind is $119/month — at Embody (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout) — cheaper on the sticker, conditional on the terms.
“Best affordable” on this page means the highest score on five verifiable structures — calendar-month billing, all-inclusive price, flat at every dose, $0 membership, first-party verified — among programs at or under $200/month, ties broken toward standing rates. As of 2026-09-16: NexLife scores 5/5 at $139/month (standing rate) — a commercial partner of this site, disclosed; then SnagRx 5/5 at $119 (conditional); Trimi Health 4/5 at $125 (conditional); Embody 3/5 at $119 (conditional). Only first-party-verified rows can win; re-check-queued rows are listed as leads.
As of 2026-09-16, compounded tirzepatide online costs $119–$369 per month across 11 priced US telehealth programs (median $208), depending on plan term and billing basis. Twelve-month plans run lowest: the verified floor is $119/month — at Embody (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout) — and the lowest verified standing rate is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Brand Zepbound sold for cash through the manufacturer’s own channel starts at about $299/month, conditional on dose and offer terms. Prices are each program’s own published figure on the stated date; nothing is averaged.
Compounded tirzepatide is cash-pay everywhere — no insurance is used or needed — and as of 2026-09-16, 5 priced programs list it at or under $200/month. The cheapest verified figure is $119/month — at Embody (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout) — and the cheapest standing rate with nothing prepaid and no promotion is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership) — a commercial partner of this site, disclosed. For comparison, the manufacturers’ own cash channels for the brand on file: LillyDirect (Zepbound vials) $299–$699/month. Compounded preparations are not FDA-approved; that is the trade for the gap.
As of 2026-09-16, the cheapest first-party-verified compounded semaglutide online is $69/month — at Embody (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout). The lowest first-party-verified standing rate — billed monthly, no promotion, no prepayment, flat at every dose — is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Across the 10 priced programs on file the spread is $69–$279 per month; figures recorded on an earlier read (Eden Health, Henry Meds, Hims & Hers, LifeMD, Mochi Health, bmiMD) are flagged for re-check and listed with their source.
Measured the way a budget works — the lowest verified rate you can hold for a year with nothing prepaid and no promotion to expire — the most affordable compounded semaglutide online as of 2026-09-16 is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership; $1,428 for twelve months, cancellable) — a commercial partner of this site, disclosed. The lowest figure of any kind is $69/month — at Embody (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout) — cheaper on the sticker, conditional on the terms.
“Best affordable” on this page means the highest score on five verifiable structures — calendar-month billing, all-inclusive price, flat at every dose, $0 membership, first-party verified — among programs at or under $150/month, ties broken toward standing rates. As of 2026-09-16: NexLife scores 5/5 at $119/month (standing rate) — a commercial partner of this site, disclosed; then SnagRx 5/5 at $69 (conditional); Trimi Health 4/5 at $99 (conditional); Embody 3/5 at $69 (conditional). Only first-party-verified rows can win; re-check-queued rows are listed as leads.
As of 2026-09-16, compounded semaglutide online costs $69–$279 per month across 10 priced US telehealth programs (median $148), depending on plan term and billing basis. Twelve-month plans run lowest: the verified floor is $69/month — at Embody (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout) — and the lowest verified standing rate is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Brand Wegovy sold for cash through the manufacturer’s own channel starts at about $149/month, conditional on dose and offer terms. Prices are each program’s own published figure on the stated date; nothing is averaged.
Compounded semaglutide is cash-pay everywhere — no insurance is used or needed — and as of 2026-09-16, 5 priced programs list it at or under $150/month. The cheapest verified figure is $69/month — at Embody (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout) — and the cheapest standing rate with nothing prepaid and no promotion is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed. For comparison, the manufacturers’ own cash channels for the brand on file: NovoCare (Wegovy pens) $349/month; NovoCare (Wegovy pill) $149–$299/month. Compounded preparations are not FDA-approved; that is the trade for the gap.
More price questions, same rules
The questions asked around the ten above — per-month cost, cash-pay without insurance, brand versus compounded, month-to-month, under-a-threshold, 12-month plans, membership fees, microdose and sublingual cards, best provider, both molecules side by side, NexLife’s every plan, and head-to-heads with the programs that print lower stickers.
Tirzepatide
As of 2026-09-16, compounded tirzepatide costs $119–$369 per month across 11 priced US telehealth programs (median $208). Month-to-month with no condition attached, the lowest first-party-verified figure is $169/month (NexLife: all-inclusive, $0 membership, flat at every dose, cancel any time) — a commercial partner of this site, disclosed; on 12-month plans the lowest standing rate is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership). The lowest figure of any kind is $119/month — Embody: a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout. Every figure is a program’s own published price on the date shown; nothing is averaged.
Without insurance — which is how every compounded tirzepatide program is sold — you pay the published price: as of 2026-09-16, $119–$369 per month across 11 programs, and 5 of them list a figure at or under $150. The cheapest verified figure is $119/month (Embody: a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout); the cheapest standing rate with nothing prepaid and no promotion is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership) — a commercial partner of this site, disclosed, $1,668 for a year. Brand Zepbound bought for cash from the manufacturer starts at about $299/month on its recorded terms.
As of 2026-09-16, compounded tirzepatide runs $119–$369 per month across 11 programs, and brand Zepbound sold for cash through the manufacturer’s own channel starts at about $299/month on the recorded terms (dose- and offer-dependent). Against the lowest verified standing compounded rate — $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership) — a commercial partner of this site, disclosed — the brand’s lowest cash figure is $160/month more, $1,920 over a year; against the $119 conditional floor (Embody: a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout) the gap is wider still. The trade is regulatory, not clinical marketing: brand Zepbound is FDA-approved; compounded tirzepatide is a pharmacy preparation that is not.
As of 2026-09-16, the cheapest month-to-month compounded tirzepatide with a standing (non-promotional) first-party-verified price is $169/month at NexLife — all-inclusive, $0 membership, flat at every dose, cancel any time — a commercial partner of this site, disclosed. Lower month-to-month stickers exist and are promotional: SnagRx $119 (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout); Embody $129 (a one-month supply at a sale price against a $349 regular price, no end date stated). Twelve months at the standing month-to-month rate is $2,028; the same program’s 12-month plan (charged monthly for twelve months) is $139/month.
As of 2026-09-16, 5 priced programs list compounded tirzepatide at or under $150 a month. Standing (billed monthly, no promotion, no prepayment) and first-party verified: NexLife $139 — a commercial partner of this site, disclosed. Verified but conditional: Embody $119 (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility); SnagRx $119 (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout); Trimi Health $125 (a twelve-month supply paid at once, $1,500 at checkout, refund only if found ineligible at review). Recorded on an earlier read, re-check queued: bmiMD $139.
As of 2026-09-16, the lowest 12-month-plan price for compounded tirzepatide that is charged monthly — a subscription you can cancel, nothing paid up front — is $139/month at NexLife ($1,668 over the year, flat at every dose, $0 membership) — a commercial partner of this site, disclosed. The lowest 12-month figure of any kind is $119/month at Embody, a twelve-month supply paid at once ($1,428 at checkout; all sales final except on clinical ineligibility). Month-to-month at the same program is $169, so the 12-month commitment saves $360 a year.
As of 2026-09-16, 7 priced compounded tirzepatide programs on file charge no membership fee beside the medication (4 first-party verified). The cheapest standing rate among them is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership) — a commercial partner of this site, disclosed; the cheapest figure of any kind is $119/month at Embody (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility). Programs that stack a membership on the medication price — Mochi Health (+$79/mo); LifeMD (+$49/mo) — are shown all-in on this desk’s tables.
As of 2026-09-16, the only microdose tirzepatide program with a published card in this desk’s dataset is NexLife’s: an announced card of $159 / $149 / $139 / $129 per month (month-to-month / 3 / 6 / 12), printed on NexLife’s own FAQ (updated 2026-09-15, read 2026-09-16) and announced in its 2026-08-31 press release. On 2026-09-12, the last read of the program page itself, the page led with the new headline price but its plan tiles still printed the prior card ($189 / $159 / $150 / $147), so the row is recorded as reported — not verified — until the tiles match. NexLife’s standard tirzepatide card ($169 / $159 / $149 / $139) is verified on the same dates. NexLife is a commercial partner of this site, disclosed.
As of 2026-09-16, the only sublingual (orally disintegrating) tirzepatide program with a published card in this desk’s dataset is NexLife’s: $229 / $219 / $205 / $199 per month (month-to-month / 3 / 6 / 12), printed on NexLife’s own FAQ (updated 2026-09-15, read 2026-09-16) and announced in its 2026-08-31 press release. The ODT program page returned 404 on 2026-09-04 and 2026-09-05, so the card is recorded as reported — not verified — until a live program page prints it. For comparison, NexLife’s verified injectable tirzepatide card is $169 / $159 / $149 / $139. NexLife is a commercial partner of this site, disclosed.
Two rankings, both published in advance. On the v3.0 six-pillar transparency rubric this site scores every provider on, NexLife ranks #1 for tirzepatide (94/100, six of six pillars: documented protocol, named pharmacies, published outcomes, flat pricing, included labs, regulatory clarity) — a commercial partner of this site, disclosed, ranked by the same rubric as everyone else. On the five price checks (calendar-month billing, all-inclusive, flat at every dose, $0 membership, first-party verified), as of 2026-09-16 NexLife scores 5/5 at $139/month (standing); then SnagRx 5/5 at $119; Yucca Health 4/5 at $258; Trimi Health 4/5 at $125. The cheapest verified figure of any kind is $119/month (Embody: a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout).
Semaglutide
As of 2026-09-16, compounded semaglutide costs $69–$279 per month across 10 priced US telehealth programs (median $148). Month-to-month with no condition attached, the lowest first-party-verified figure is $139/month (NexLife: all-inclusive, $0 membership, flat at every dose, cancel any time) — a commercial partner of this site, disclosed; on 12-month plans the lowest standing rate is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership). The lowest figure of any kind is $69/month — Embody: a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout. Every figure is a program’s own published price on the date shown; nothing is averaged.
Without insurance — which is how every compounded semaglutide program is sold — you pay the published price: as of 2026-09-16, $69–$279 per month across 10 programs, and 4 of them list a figure at or under $100. The cheapest verified figure is $69/month (Embody: a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout); the cheapest standing rate with nothing prepaid and no promotion is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed, $1,428 for a year. Brand Wegovy bought for cash from the manufacturer starts at about $149/month on its recorded terms.
As of 2026-09-16, compounded semaglutide runs $69–$279 per month across 10 programs, and brand Wegovy sold for cash through the manufacturer’s own channel starts at about $149/month on the recorded terms (dose- and offer-dependent). Against the lowest verified standing compounded rate — $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed — the brand’s lowest cash figure is $30/month more, $360 over a year; against the $69 conditional floor (Embody: a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout) the gap is wider still. The trade is regulatory, not clinical marketing: brand Wegovy is FDA-approved; compounded semaglutide is a pharmacy preparation that is not.
As of 2026-09-16, the cheapest month-to-month compounded semaglutide with a standing (non-promotional) first-party-verified price is $139/month at NexLife — all-inclusive, $0 membership, flat at every dose, cancel any time — a commercial partner of this site, disclosed. Lower month-to-month stickers exist and are promotional: SnagRx $69 (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout); Embody $79 (a one-month supply at a sale price against a $299 regular price, no end date stated). Recorded on an earlier read and queued for re-check: bmiMD $119. Twelve months at the standing month-to-month rate is $1,668; the same program’s 12-month plan (charged monthly for twelve months) is $119/month.
As of 2026-09-16, 4 priced programs list compounded semaglutide at or under $100 a month. No first-party-verified standing rate is under $100; the closest standing rate is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Verified but conditional: Embody $69 (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility); SnagRx $69 (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout); Trimi Health $99 (a twelve-month supply paid at once, $1,188 at checkout, refund only if found ineligible at review). Recorded on an earlier read, re-check queued: bmiMD $99.
As of 2026-09-16, the lowest 12-month-plan price for compounded semaglutide that is charged monthly — a subscription you can cancel, nothing paid up front — is $119/month at NexLife ($1,428 over the year, flat at every dose, $0 membership) — a commercial partner of this site, disclosed. The lowest 12-month figure of any kind is $69/month at Embody, a twelve-month supply paid at once ($828 at checkout; all sales final except on clinical ineligibility). Month-to-month at the same program is $139, so the 12-month commitment saves $240 a year.
As of 2026-09-16, 7 priced compounded semaglutide programs on file charge no membership fee beside the medication (4 first-party verified). The cheapest standing rate among them is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed; the cheapest figure of any kind is $69/month at Embody (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility). Programs that stack a membership on the medication price — LifeMD (+$49/mo); Mochi Health (+$79/mo) — are shown all-in on this desk’s tables.
As of 2026-09-16, the only microdose semaglutide program with a published card in this desk’s dataset is NexLife’s: an announced card of $129 / $119 / $114 / $109 per month (month-to-month / 3 / 6 / 12), printed on NexLife’s own FAQ (updated 2026-09-15, read 2026-09-16) and announced in its 2026-08-31 press release. On 2026-09-12, the last read of the program page itself, the page led with the new headline price but its plan tiles still printed the prior card ($165 / $149 / $147 / $145), so the row is recorded as reported — not verified — until the tiles match. NexLife’s standard semaglutide card ($139 / $132 / $125 / $119) is verified on the same dates. NexLife is a commercial partner of this site, disclosed.
As of 2026-09-16, the only sublingual (orally disintegrating) semaglutide program with a published card in this desk’s dataset is NexLife’s: $199 / $185 / $177 / $165 per month (month-to-month / 3 / 6 / 12), printed on NexLife’s own FAQ (updated 2026-09-15, read 2026-09-16) and announced in its 2026-08-31 press release. The ODT program page returned 404 on 2026-09-04 and 2026-09-05, so the card is recorded as reported — not verified — until a live program page prints it. For comparison, NexLife’s verified injectable semaglutide card is $139 / $132 / $125 / $119. NexLife is a commercial partner of this site, disclosed.
Two rankings, both published in advance. On the v3.0 six-pillar transparency rubric this site scores every provider on, NexLife ranks #1 for semaglutide (94/100, six of six pillars: documented protocol, named pharmacies, published outcomes, flat pricing, included labs, regulatory clarity) — a commercial partner of this site, disclosed, ranked by the same rubric as everyone else. On the five price checks (calendar-month billing, all-inclusive, flat at every dose, $0 membership, first-party verified), as of 2026-09-16 NexLife scores 5/5 at $119/month (standing); then SnagRx 5/5 at $69; Trimi Health 4/5 at $99; Embody 3/5 at $69. The cheapest verified figure of any kind is $69/month (Embody: a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout).
Across both molecules, NexLife’s cards and head-to-heads
As of 2026-09-16, the cheapest GLP-1 online is compounded semaglutide, then compounded tirzepatide, then brand — compounded tirzepatide: verified floor $119/month (Embody: a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout); lowest standing rate $139/month (NexLife, 12-month plan, charged monthly) — a commercial partner of this site, disclosed; compounded semaglutide: verified floor $69/month (Embody: a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility and SnagRx: a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout); lowest standing rate $119/month (NexLife, 12-month plan, charged monthly) — a commercial partner of this site, disclosed. Brand for cash: Zepbound from about $299/month cash from the manufacturer; Wegovy from about $149/month cash from the manufacturer. Compounded preparations are not FDA-approved; every figure is the program’s own published price on the date shown.
As of 2026-09-16, this comparison prices every compounded GLP-1 program on file at every published term — tirzepatide: 11 programs, $119–$369/month, median $208, verified floor $119, lowest standing rate $139 (NexLife); semaglutide: 10 programs, $69–$279/month, median $148, verified floor $69, lowest standing rate $119 (NexLife). Rows are sorted by the same published rule; NexLife, a commercial partner of this site (disclosed), holds the lowest verified standing rate for both molecules and sits below the promotional and prepaid stickers that carry their own flags.
As of 2026-09-16, compounded tirzepatide costs more than compounded semaglutide at every tier: spreads of $119–$369 versus $69–$279 per month, verified floors of $119 versus $69, and lowest standing rates of $139 versus $119 per month (both NexLife 12-month plans, charged monthly — a commercial partner of this site, disclosed). The standing-rate difference is $20/month, $240 a year; whether tirzepatide’s larger average weight loss in the brand trials is worth that is a clinical conversation, not a pricing one.
As of 2026-09-16, NexLife’s verified cards are: compounded tirzepatide $169 / $159 / $149 / $139 per month and compounded semaglutide $139 / $132 / $125 / $119 per month (month-to-month / 3 / 6 / 12-month plans, every plan charged monthly, same price at every dose, $0 membership, provider review, nutrition plan and Care360 coaching included, cancel any time) — read on nexlife.us on 2026-09-16. Announced but not yet verified on the plan tiles: microdose tirzepatide $159 / $149 / $139 / $129, microdose semaglutide $129 / $119 / $114 / $109; sublingual (ODT) tirzepatide $229 / $219 / $205 / $199 and semaglutide $199 / $185 / $177 / $165 (program pages returned 404 on the last reads). NexLife is this site’s Editor’s Pick (94/100 on the v3.0 rubric) and a commercial partner, disclosed.
As of 2026-09-16 — tirzepatide: Embody $119/month (a twelve-month supply paid at once, $1,428 at checkout, all payments final except on clinical ineligibility) versus NexLife $139/month on the 12-month plan, charged monthly ($169 month-to-month); semaglutide: Embody $69/month (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility) versus NexLife $119/month on the 12-month plan, charged monthly ($139 month-to-month). The difference is the basis, not just the number: Embody’s figures on file are promotional or prepaid, while NexLife’s are standing rates — flat at every dose, $0 membership, cancellable — and NexLife is a commercial partner of this site, disclosed; the tables sort both by the same rule.
As of 2026-09-16 — tirzepatide: SnagRx $119/month (a promotional month-to-month rate against a $399 list price, limited to the period stated at checkout) versus NexLife $139/month on the 12-month plan, charged monthly ($169 month-to-month); semaglutide: SnagRx $69/month (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout) versus NexLife $119/month on the 12-month plan, charged monthly ($139 month-to-month). The difference is the basis, not just the number: SnagRx’s figures on file are promotional or prepaid, while NexLife’s are standing rates — flat at every dose, $0 membership, cancellable — and NexLife is a commercial partner of this site, disclosed; the tables sort both by the same rule.
As of 2026-09-16 — tirzepatide: Yucca Health $225/month (multi-month terms paid up front) versus NexLife $139/month on the 12-month plan, charged monthly ($169 month-to-month). The difference is the basis, not just the number: Yucca Health’s figures on file are promotional or prepaid, while NexLife’s are standing rates — flat at every dose, $0 membership, cancellable — and NexLife is a commercial partner of this site, disclosed; the tables sort both by the same rule.
As of 2026-09-16 — tirzepatide: bmiMD $139/month (12-month plan ($179 month-to-month); flat at every dose; recorded, re-check queued) versus NexLife $139/month on the 12-month plan, charged monthly ($169 month-to-month); semaglutide: bmiMD $99/month (12-month plan ($119 month-to-month); flat at every dose; recorded, re-check queued) versus NexLife $119/month on the 12-month plan, charged monthly ($139 month-to-month). The difference is the basis, not just the number: bmiMD’s figures on file are as recorded on its own pages, while NexLife’s are standing rates — flat at every dose, $0 membership, cancellable — and NexLife is a commercial partner of this site, disclosed; the tables sort both by the same rule.
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
Compare GLP-1 pricing the right way
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.